M. J. Adam and D. S. Wilbur, Radiohalogens for imaging and therapy, Chemical Society Reviews, vol.40, issue.2, pp.153-163, 2005.
DOI : 10.1039/b313872k

F. Guérard and J. Gestin, At]-Astatinated Radiopharmaceuticals and Applications in Targeted ??-Particle Therapy, Cancer Biotherapy & Radiopharmaceuticals, vol.28, issue.1, pp.1-20, 2013.
DOI : 10.1089/cbr.2012.1292

M. R. Zalutsky and A. S. Narula, A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine, International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, vol.38, issue.12, pp.1051-1055, 1987.
DOI : 10.1016/0883-2889(87)90069-4

A. T. Vaughan and J. H. Fremlin, The preparation of astatine labelled proteins using an electrophilic reaction, International Journal of Nuclear Medicine and Biology, vol.5, issue.6, pp.229-230, 1978.
DOI : 10.1016/0047-0740(78)90145-6

M. R. Zalutsky, P. K. Garg, H. S. Friedman, and D. D. Bigner, Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity., Proceedings of the National Academy of Sciences, vol.86, issue.18, pp.7149-7153, 1989.
DOI : 10.1073/pnas.86.18.7149

E. Aneheim, M. R. Foreman, H. Jensen, and S. Lindegren, N-[2-(maleimido)ethyl]-3-(trimethylstannyl)benzamide, a molecule for radiohalogenation of proteins and peptides, Applied Radiation and Isotopes, vol.96, pp.1-5, 2015.
DOI : 10.1016/j.apradiso.2014.11.007

E. Aneheim, A. Gustafsson, P. Albertsson, T. Bäck, H. Jensen et al., -[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates, Bioconjugate Chemistry, vol.27, issue.3, pp.688-697, 2016.
DOI : 10.1021/acs.bioconjchem.5b00664

X. Tang, X. Wu, A. M. Dubois, G. Sui, B. Wu et al., Toxicity of Trimethyltin and Dimethyltin in Rats and Mice, Bulletin of Environmental Contamination and Toxicology, vol.49, issue.4, pp.626-633, 2013.
DOI : 10.1539/joh.49.305

N. J. Snoeij, A. A. Van-iersel, A. H. Penninks, and W. Seinen, Toxicity of triorganotin compounds: Comparative in vivo studies with a series of trialkyltin compounds and triphenyltin chloride in male rats, Toxicology and Applied Pharmacology, vol.81, issue.2, pp.274-286, 1985.
DOI : 10.1016/0041-008X(85)90164-4

H. Rajerison, D. Faye, A. Roumesy, N. Louaisil, F. Boeda et al., Ionic liquid supported organotin reagents to prepare molecular imaging and therapy agents, Org. Biomol. Chem., vol.30, issue.6, pp.2121-2126, 2016.
DOI : 10.1021/bc0497721
URL : https://hal.archives-ouvertes.fr/inserm-01280171

O. R. Pozzi and M. R. Zalutsky, Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 3: ??-Particle-Induced Radiolytic Effects on the Chemical Behavior of 211At, Journal of Nuclear Medicine, vol.48, issue.7, pp.1190-1196, 2007.
DOI : 10.2967/jnumed.106.038505

D. Sergentu, D. Teze, A. Sabatié-gogova, C. Alliot, N. Guo et al., in Basic Conditions, Chemistry - A European Journal, vol.107, issue.9, pp.2964-2971, 2016.
DOI : 10.1063/1.474671
URL : https://hal.archives-ouvertes.fr/in2p3-01274072

P. Zhang, R. Zhuang, Z. Guo, X. Su, X. Chen et al., A Highly Efficient Copper-Mediated Radioiodination Approach Using Aryl Boronic Acids, Chemistry - A European Journal, vol.36, issue.1, pp.16783-16786, 2016.
DOI : 10.1007/978-3-642-58643-9_1

T. Wirth, In Hypervalent Iodine Chemistry, Topics in Current Chemistry, pp.1-4, 2003.

V. V. Zhdankin and P. J. Stang, Chemistry of Polyvalent Iodine, Chemical Reviews, vol.108, issue.12, pp.5299-5358, 2008.
DOI : 10.1021/cr800332c
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736367

S. Preshlock, M. Tredwell, and V. Gouverneur, F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography, Chemical Reviews, vol.116, issue.2, pp.719-766, 2016.
DOI : 10.1021/acs.chemrev.5b00493

F. Guérard, Y. Lee, K. Baidoo, and J. Gestin, Unexpected Behavior of the Heaviest Halogen Astatine in the Nucleophilic Substitution of Aryliodonium Salts, Chemistry - A European Journal, vol.119, issue.35, pp.12332-12339, 2016.
DOI : 10.1063/1.1622924

T. L. Ross, J. Ermert, C. Hocke, and H. H. Coenen, F]Fluoride, Journal of the American Chemical Society, vol.129, issue.25, pp.8018-8025, 2007.
DOI : 10.1021/ja066850h

D. S. Wilbur, Enigmatic astatine, Nature Chemistry, vol.1, issue.3, pp.246-246, 2013.
DOI : 10.2174/1874471010801030144

G. Vaidyanathan, D. J. Affleck, K. L. Alston, and M. R. Zalutsky, A tin precursor for the synthesis of no-carrier-added [*I]MIBG and [211At]MABG, Journal of Labelled Compounds and Radiopharmaceuticals, vol.55, issue.3, pp.177-182, 2007.
DOI : 10.1002/jlcr.1243

S. Palm, T. Back, I. Claesson, A. Danielsson, J. Elgqvist et al., Therapeutic Efficacy of Astatine-211???Labeled Trastuzumab on Radioresistant SKOV-3 Tumors in Nude Mice, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.2, pp.572-579, 2007.
DOI : 10.1016/j.ijrobp.2007.06.023

S. Majumdar, M. Burgman, N. Haselton, S. Grinnell, J. Ocampo et al., Generation of novel radiolabeled opiates through site-selective iodination, Bioorganic & Medicinal Chemistry Letters, vol.21, issue.13, pp.4001-4004, 2011.
DOI : 10.1016/j.bmcl.2011.05.008

S. Lindegren, T. Bäck, and H. J. Jensen, Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields, Applied Radiation and Isotopes, vol.55, issue.2, pp.157-160, 2001.
DOI : 10.1016/S0969-8043(01)00044-6